Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

779 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A prospective clinical trial of GVHD prophylaxis with Post-Transplant Cyclophosphamide and Abatacept.
Koura D, Dykes KC, Goodman AM, Costello CL, Mulroney C, Mangan JK, Tanaka TN, Ball ED, Hamdan A, Jeong AR, Mirocha J, Zhang Q, Ogrodnik P, McConnell K, Maroge JJ, Padilla M, Morris GP, Tzachanis D. Koura D, et al. Among authors: padilla m. Blood Adv. 2025 Jun 24:bloodadvances.2024015094. doi: 10.1182/bloodadvances.2024015094. Online ahead of print. Blood Adv. 2025. PMID: 40554429
Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial.
Kambhampati S, Fakhri B, Ai WZ, Kaplan LD, Tuscano JM, Wieduwilt MJ, Sudhindra A, Cavallone E, Reiner J, Aoun C, Castillo M, Martinelli M, Ta T, Le D, Padilla M, Crawford E, Andreadis CB. Kambhampati S, et al. Among authors: padilla m. Clin Lymphoma Myeloma Leuk. 2021 Mar;21(3):139-146. doi: 10.1016/j.clml.2020.12.020. Epub 2020 Dec 24. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33478921 Clinical Trial.
Antigen avidity drives the durability of the vaccine immune response.
Weidner NG, Padilla MV, Pruitt L, Cottrell CA, Gonzales K, Kalyuzhniy O, Kubitz M, Alavi N, Phelps N, Weglarz M, Schief WR, Abbott RK. Weidner NG, et al. Among authors: padilla mv. bioRxiv [Preprint]. 2025 Apr 27:2025.04.18.649567. doi: 10.1101/2025.04.18.649567. bioRxiv. 2025. PMID: 40625639 Free PMC article. Preprint.
Patient-attributable delay and its impact on two-year survival in breast cancer: A multicenter prospective cohort study.
Martín-García D, García-Aranda M, Varela-Moreno E, Padilla-Ruiz M, Zarcos-Pedrinaci I, Rivas-Ruiz F, Téllez T, García-Gutiérrez S, González N, Rivero A, Sarasqueta C, Perestelo-Pérez L, Castells X, Quintana JM, Sala M, Redondo M; REDISSEC/CAMISS Group. Martín-García D, et al. Eur J Surg Oncol. 2025 Jun 24;51(8):110280. doi: 10.1016/j.ejso.2025.110280. Online ahead of print. Eur J Surg Oncol. 2025. PMID: 40618651 Free article.
Temporal trends and public health implications of dengue in Guatemala: A decade of challenges and emerging threats (2013-2024).
Veliz SPZ, Signor LDCC, Gonzalez N, Araque J, Hernández F, Ramos J, Nuñez N, Vasquez F, Barrientos A, Lima EJAB, Tejeda ES, Padilla MLM, Ambikan A, Neogi U. Veliz SPZ, et al. Among authors: padilla mlm. IJID Reg. 2025 May 10;15:100667. doi: 10.1016/j.ijregi.2025.100667. eCollection 2025 Jun. IJID Reg. 2025. PMID: 40520254 Free PMC article.
To Stay or To Go? Debate Regarding US News and World Report Pharmacy Program Rankings.
O'Connor SK, Sierra CM, Willson MN, Maerten-Rivera J, Lindsey CC, Crill CM, Frankart LM, Moote R, Mosley A, Padilla M, Prisco J, Smith S. O'Connor SK, et al. Among authors: padilla m. Am J Pharm Educ. 2025 Jun 9;89(8):101432. doi: 10.1016/j.ajpe.2025.101432. Online ahead of print. Am J Pharm Educ. 2025. PMID: 40499617 Free article.
779 results